LifeStance Health Group Inc (NASDAQ: LFST) has seen a decline in its stock price by -1.04 in relation to its previous close of 6.74. However, the company has experienced a -4.58% decline in its stock price over the last five trading sessions. zacks.com reported 2024-08-30 that The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Is It Worth Investing in LifeStance Health Group Inc (NASDAQ: LFST) Right Now?
Moreover, the 36-month beta value for LFST is 1.19. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 4 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for LFST is 111.03M and currently, short sellers hold a 10.92% of that float. On September 12, 2024, LFST’s average trading volume was 1.62M shares.
LFST’s Market Performance
LFST stock saw an increase of -4.58% in the past week, with a monthly gain of 14.21% and a quarterly increase of 21.94%. The volatility ratio for the week is 4.73%, and the volatility levels for the last 30 days are 4.40% for LifeStance Health Group Inc (LFST). The simple moving average for the last 20 days is 6.04% for LFST stock, with a simple moving average of 5.64% for the last 200 days.
Analysts’ Opinion of LFST
Many brokerage firms have already submitted their reports for LFST stocks, with Barclays repeating the rating for LFST by listing it as a “Underweight.” The predicted price for LFST in the upcoming period, according to Barclays is $7 based on the research report published on January 03, 2024 of the current year 2024.
TD Cowen, on the other hand, stated in their research note that they expect to see LFST reach a price target of $9, previously predicting the price at $8. The rating they have provided for LFST stocks is “Market Perform” according to the report published on May 15th, 2023.
Morgan Stanley gave a rating of “Overweight” to LFST, setting the target price at $8 in the report published on January 06th of the previous year.
LFST Trading at 14.97% from the 50-Day Moving Average
After a stumble in the market that brought LFST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.50% of loss for the given period.
Volatility was left at 4.40%, however, over the last 30 days, the volatility rate increased by 4.73%, as shares surge +18.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +32.51% upper at present.
During the last 5 trading sessions, LFST fell by -4.08%, which changed the moving average for the period of 200-days by +2.37% in comparison to the 20-day moving average, which settled at $6.34. In addition, LifeStance Health Group Inc saw -14.81% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFST starting from Varanakis Ann, who sale 5,269 shares at the price of $6.28 back on Aug 23 ’24. After this action, Varanakis Ann now owns 263,007 shares of LifeStance Health Group Inc, valued at $33,089 using the latest closing price.
KEVIN M MULLINS, the Former officer of LifeStance Health Group Inc, proposed sale 1,400,000 shares at $5.74 during a trade that took place back on Aug 21 ’24, which means that KEVIN M MULLINS is holding shares at $8,041,600 based on the most recent closing price.
Stock Fundamentals for LFST
Current profitability levels for the company are sitting at:
- -0.12 for the present operating margin
- 0.25 for the gross margin
The net margin for LifeStance Health Group Inc stands at -0.13. The total capital return value is set at -0.07. Equity return is now at value -10.32, with -7.04 for asset returns.
Based on LifeStance Health Group Inc (LFST), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is -6.07.
Currently, EBITDA for the company is -106.91 million with net debt to EBITDA at -7.48. When we switch over and look at the enterprise to sales, we see a ratio of 2.57. The receivables turnover for the company is 6.91for trailing twelve months and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.22.
Conclusion
To wrap up, the performance of LifeStance Health Group Inc (LFST) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
